Bradshaw urges generics industry to support user fees

Share this article:
Days after resigning to join the law firm of Hunton & Williams, FDA chief counsel Sheldon Bradshaw took advantage of his sudden freedom to strongly urge the generic drug industry to support user fees as the best means for reducing the review backlog at the agency. More funding for this from the administration is unlikely, he said.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions